The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users
暂无分享，去创建一个
T. Kosten | J. Henningfield | A. Mattarei | S. Comai | M. Shram | C. Inturrisi | S. De Martin | S. Traversa | C. Gorodetzky | G. Apseloff | A. Buchhalter | Paolo L. Manfredi | J. Ashworth | C. O'gorman | M. Pappagallo | Clotilde Guidetti | F. Sapienza | J. Huston | F. Folli | Ryan Lanier | Frank L Vocci | Andrea Mattarei | Sara De Martin | F. Vocci | Frank L Sapienza